Affiliation: Massachusetts General Hospital
- The clinical application and cost analysis of fine-needle aspiration biopsy in the diagnosis of mass lesions in sarcoidosisR Tambouret
James Homer Wright Laboratories of the General Hospital and the Department of Pathology, Harvard Medical School, Boston, MA 02114, USA
Chest 117:1004-11. 2000..We analyzed the utility and relative cost-effectiveness of fine-needle aspiration biopsy (FNAB) in the clinical investigation of patients with both suspected and unsuspected sarcoidosis...
- Screening for cervical cancer in low-resource settings in 2011Rosemary Tambouret
Department of Pathology, Massachusetts General Hospital, Boston, MA 02114, USA
Arch Pathol Lab Med 137:782-90. 2013..Cervical cancer remains the most common malignancy in women living in low- and middle-income countries, despite the decline of the disease in countries where cervical cytology screening programs have been implemented...
- The evolution of the Papanicolaou smearRosemary H Tambouret
Cytopathology Fellowship Program, Massachusetts General Hospital, Boston, MA, USA
Clin Obstet Gynecol 56:3-9. 2013..In this article, the origins of the Pap smear as a screening method and the many changes associated with the use of the Pap smear are detailed...
- Low-grade squamous intraepithelial lesion, cannot exclude high-grade squamous intraepithelial lesion: a category with an increased outcome of high-grade lesions: use as a quality assurance measureHa T Nishino
James Homer Wright Laboratory of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, USA
Am J Clin Pathol 138:198-202. 2012..These data may be useful for establishing and/or realigning the diagnostic criteria for this equivocal cytologic interpretation endorsed by a pathology practice...
- Longitudinal clinical evaluation of a novel antibody cocktail for detection of high-grade squamous intraepithelial lesions on cervical cytology specimensRosemary H Tambouret
James Homer Wright Pathology Laboratory, Division of Cytopathology, Massachusetts General Hospital, Boston, MA 02114, USA
Arch Pathol Lab Med 132:918-25. 2008..Although cervical cancer screening by cytology is successful, the test continues to show relatively poor operating characteristics. Cell cycle markers may enhance detection of high-grade squamous intraepithelial lesions...
- Endometrial endometrioid adenocarcinoma with a deceptive pattern of spread to the uterine cervix: a manifestation of stage IIb endometrial carcinoma liable to be misinterpreted as an independent carcinoma or a benign lesionRosemary Tambouret
James Homer Wright Pathology Laboratories, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA
Am J Surg Pathol 27:1080-8. 2003..It is important for both therapeutic and prognostic reasons that the cervical abnormality is not misinterpreted as a benign or malignant primary endocervical glandular process...
- Significance of histiocytes in cervical smears from peri/postmenopausal womenR Tambouret
James Homer Wright Laboratories, Massachusetts General Hospital, Department of Pathology, Harvard Medical School, Boston, Massachusetts 02114, USA
Diagn Cytopathol 24:271-5. 2001....
- Cytologic diagnosis of dysplasia in the alimentary tractRosemary Tambouret
Department of Pathology, Massachusetts General Hospital, Boston 02114, USA
Semin Diagn Pathol 19:38-47. 2002....
- The many faces of atrophy in gynecologic cytologyRosemary H Tambouret
Department of Pathology, Warren 2, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA
Clin Lab Med 23:659-79. 2003..There is no substitute for a thorough evaluation of each case, and with continued experience and understanding of these principles, the correct interpretations, and, ultimately, correct management of patients, can be optimized...
- Whole-slide imaging digital pathology as a platform for teleconsultation: a pilot study using paired subspecialist correlationsDavid C Wilbur
Department of Pathology, James Homer Wright Pathology Laboratories, Massachusetts General Hospital, and the Department of Pathology, Harvard Medical School, Boston, MA 02114, USA
Arch Pathol Lab Med 133:1949-53. 2009..Before implementation, technical issues, pathologist adaptability, and morphologic pitfalls must be well characterized...
- Human papillomavirus testing using hybrid capture II with SurePath collection: initial evaluation and longitudinal data provide clinical validation for this methodVincent Ko
Division of Cytopathology, Department of Pathology, Massachusetts General Hospital, Boston, MA 02114, USA
Cancer 108:468-74. 2006..Clinical validation of non-FDA (Food and Drug Administration)-approved methods is therefore important because of the high volume of such tests and the implications for missed high-grade lesions if test performance is not optimal...
- Testing for HPV as an objective measure for quality assurance in gynecologic cytology: positive rates in equivocal and abnormal specimens and comparison with the ASCUS to SIL ratioVincent Ko
Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts 02114, USA
Cancer 111:67-73. 2007..High-risk HPV (hrHPV) testing is an objective test for a known viral carcinogen, and hrHPV may be more useful in monitoring the quality of ASCUS interpretations...
- Psammoma bodies in cervicovaginal cytology specimens: a clinicopathological analysis of 31 casesJoseph Misdraji
Department of Pathology and Cytopathology Laboratory, Massachusetts General Hospital, Harvard Medical School, 55 Fruit Street, Boston, MA 02114, USA
Gynecol Oncol 103:238-46. 2006..Psammoma bodies in cervicovaginal cytology specimens are associated with malignant and benign conditions. Few studies have evaluated which features distinguish patients with underlying malignancy from those with benign conditions...
- The negative predicative value of breast fine-needle aspiration biopsy: the Massachusetts General Hospital experienceStephen K Lau
Department of Pathology, Grady Memorial Hospital, Emory University Medical School, Atlanta, Georgia, USA
Breast J 10:487-91. 2004..However, in the setting of a triple-negative test, the NPV in our patient population was 100%, reassuring the patient and clinician that clinical follow-up and not surgical intervention was sufficient for proper patient care...
- Cytologic features of endocervical glandular lesions: comparison of SurePath, ThinPrep, and conventional smear specimen preparationsNicole A Belsley
James Homer Wright Pathology Laboratories, Massachusetts General Hospital, Boston, Massachusetts 02114, USA
Diagn Cytopathol 36:232-7. 2008..Keeping these differences in mind, virtually the same criteria can be used to identify endocervical glandular lesions in all three specimen types...
- An approach to post-radical trachelectomy vaginal-isthmus cytologyKenan Sauder
Department of Pathology, Massachusetts General Hospital, Boston, MA, USA
Diagn Cytopathol 37:437-42. 2009..In particular, a primary diagnosis of adenocarcinoma makes differentiating benign reactive glandular cells from recurrence a critical issue...
- Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 29-2006. A 43-year-old woman with painful nodules on the fingertips, shortness of breath, and fatigueKaren H Costenbader
Department of Rheumatology, Immunology, and Allergy, Brigham and Women s Hospital, Boston, USA
N Engl J Med 355:1263-72. 2006